Notably, in clinical samples, miR-146aHigh/NumbLow tumors had an increased number of tumor-infiltrating CD66+ neutrophils and a decreased number of tumor-infiltrating CD8+ T cells, indicating an immunosuppressive TME (55). The gene discussed is CD8A; the disease is neoplasm.